Indrayani Biotech (BOM:526445) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 28, 2026)


BOM:526445 Indrayani Biotech Ltd BOM:526445
51 GF Score
Price ₹9.70
GF Value ₹40.73
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Indrayani Biotech Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Indrayani Biotech's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:526445 vs CTAS, CPRT, ULS: Margin of Safety % (DCF Earnings Based) Comparison

For the Specialty Business Services subindustry, Indrayani Biotech's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indrayani Biotech Margin of Safety % (DCF Earnings Based) vs Business Services Industry

For the Business Services industry and Industrials sector, Indrayani Biotech's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Indrayani Biotech's Margin of Safety % (DCF Earnings Based) falls into.


BOM:526445
51GF Score
Indrayani Biotech Ltd BOM:526445
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Indrayani Biotech (BOM:526445) Overvalued in 2026?

Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued. The current stock price of ₹9.70 is trading 76.2% below its estimated GF Value™ of ₹40.73. GuruFocus considers Indrayani Biotech to be Possible Value Trap.

Key valuation signals for BOM:526445:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹40.73 vs. price of ₹9.70 (76.2% below fair value)
  • GF Score™: 51/100 with 7 warning signs

No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indrayani Biotech Business Description

Address Module No. 33, Block 1, 3rd Floor, SIDCO Electronic Complex, Thiru-vi-ka Industrial Estate, Guindy, Chennai, TN, IND, 600032
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
51GF Score

Get the complete analysis for BOM:526445

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.70
Price
₹40.73
GF Value